Insmed (INSM) Gross Margin (QoQ) (2019 - 2026)
Powered by 
Analysis
Insmed (INSM) Gross Margin (QoQ) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 204.83 Bn | 190.84 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.56 Bn | 176.38 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.62 Bn | 122.77 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 80.63 Bn | 72.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.92 Bn | 55.73 Bn | 1.37 Bn |
| 6 | Moderna | 58.39 Bn | 53.25 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.55 Bn | 30.24 Bn | 992.69 Mn |
| 8 | Biogen | 31.93 Bn | 30.64 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.68 Bn | 29.68 Bn | 1.16 Mn |
| 10 | Insmed | 27.84 Bn | 26.68 Bn | 358.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -30.00 |
| Mar 31, 2026 | 126.00 |
| Dec 31, 2025 | 387.00 |
| Sep 30, 2025 | 551.00 |
| Jun 30, 2025 | -321.00 |
| Mar 31, 2025 | 212.00 |
| Dec 31, 2024 | -238.00 |
| Sep 30, 2024 | 55.00 |
| Jun 30, 2024 | -8.00 |
| Mar 31, 2024 | -109.00 |
| Dec 31, 2023 | -91.00 |
| Sep 30, 2023 | 36.00 |
| Jun 30, 2023 | -28.00 |
| Mar 31, 2023 | 83.00 |
| Dec 31, 2022 | -215.00 |
| Sep 30, 2022 | 525.00 |
| Jun 30, 2022 | -218.00 |
| Mar 31, 2022 | 72.00 |
| Dec 31, 2021 | -190.00 |
| Sep 30, 2021 | 211.00 |